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Hepatocellularcarcinoma arising in a patient with genetic haemachromatosis, without cirrhosis, has
only been described once previously. We present a patient with a 15 year history of genetic
haemachromatosis who underwent resection ofa hepatocellular carcinoma in a liver with normal
architecture.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is a well known compli-
cation ofgenetic haemochromatosis (GH), the estimated
relative risk being approximately 220. It is widely stated
thatHCC develops only in patients with cirrhosis inGH2,3
and most recently "there is no published report of the
occurence of liver cancer in a noncirrhotic patient with
haemochromatosis’’4. There are two case reports ofHCC
after reversal of cirrhosis with venesection5,6, and one
report ofHCC developing in two patients with fibrosis but
no cirrhosis7. We present details of a patient withGH in
whom an HCC developed in a liver with normal
architecture.
CASE REPORT
The patient was 72 year old man when he was referred to
the Royal Free Hospital. Haemochromatosis had been
diagnosed 15 years previously when he presented with a
symmetrical smalljoint polyarthralgia and pigmentation.
There was no relevant past history; he had no risk factors
for viral hepatitis and drank little alcohol. Investigations at
that time revealed a markedly elevated ferritin and serum
iron. Liver biopsy showed grade 3 siderosis, a minor
degree of fibrosis and a moderate chronic inflammatory
cell infiltrate in the portal tracts which was thought to be
unrelated to GH. Hewas treated with regular venesection,
initially fortnightly and then monthly.A repeat biopsy one
year later showed resolution ofthe inflammation and less
siderosis. Thereafter he remained generally well but
developed non-insulin dependent diabetes.
He was followed up regularly with liver function tests
and measurements ofalphafetoprotein (AFP) which were
consistently normal until 1992, when his liver function tests
andAFP were noted to have become abnormal over a six
month interval.
Examination revealed a few spider naevi and a palpable
liver. Subsequent investigations at the Royal Free Hospital
included alkaline phosphatase 192 iu/1 (normal 35-130),
aspartate transaminase 80 iu/1 (5-40), alanine transaminase
30 iu/1 (5-40)andAFP of89,200 iu/1 (0-10). Serum iron was
17 umol/1 (11-36), iron saturation47% (20-40) and ferritin
was raised at 442 ug/1 (39-340). CT scan ofthe abdomen
revealed a well demarcated lesion in the right lobe of the
liver which, with the markedly raisedAFP, was considered
diagnostic ofan HCC. Serological markers for hepatitis B
andC viruses were negative. Bone scan and chestCT scan
revealed no evidence ofmetastatic disease.A biopsy ofthe
left lobe ofthe liver revealed no evidence ofcirrhosis but a
considerable amount ofiron within hepatocytes. Previous
liver biopsies were reviewed at this hospital.
The patient was treated initially by targeted
chemotherapy with lipiodol and epirubicin administered
angiographically via the hepatic artery; he subsequently
underwent a right partial hepatectomy. Histology ofthe
resected specimen revealed a moderately differentiated
HCC arising in a liverwith normal architecture (Figs. and
2). There was no significant portal inflammation and no
fibrosis; however, there was patchy but extensive grade 3
siderosis (Fig 3). The resection margins were free of
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Figure Gordon and Sweet’s Reticulin stain. Shows normal architecture of non-neoplastic liver. Magnification x 40
Figure 2 Haematoxylin and Eosin stain. Hepatocellular carcinoma. Magnification x 400HEPATOCELLULARCARCINOMA 165
Figure 3 Perls Prussian blue stain. Shows grade 3 siderosis in non-neoplastic liver. Magnification x 400
tumour. He had an uneventful post-operative course and
remains well 9 months later. A high AFP of 3,035 iu/1
suggests tumour recurrence although there is no clinical
or radiological evidence for this.
COMMENT
This case demonstrates that hepatocellular carcinoma
may arise in the liver ofa patientwithGH in the absence of
cirrhosis; as the patient had a surgical resection the
question of sampling error does not arise. Tumour
surveillance, therefore, is advisable in patients with GH
without cirrhosis astumoursmay arise, though very rarely.
There were no other identifiable aetiological factors which
could explain the HCC.
The pathophysiology ofiron overload is incompletely
understood. Iron is thought to cause toxicity through its
ability to form highly reactive free radicals which cause
lipid peroxidation affecting particularly mitochondrial and
microsomalmembrane lipids8. Ensuinglysosomal instabi-
lity is thought to be fundamental in producing hepatocyte
toxicity. Chronic liver cell damage itself, regardless of
aetiology, produces a proliferative response which as a
result of increased cell growth fosters secondary genetic
events. These may be activation of protoonco-genes or
inactivation of suppressor genes, thus programming the
cell for unrestrained growth9. Iron itself, again possibly by
peroxidation, has been shown to be directly mutagenic.
Animal studies with woodchucks infected with
Woodchuck Hepatitis Virus have shown thatHCCmay
develop in the presence active inflammation without the
development of cirrhosisl. It is therefore not surprising
that anHCC arose in a condition known to cause chronic
liver damage but without development ofcirrhosis; such
an event is well recognised in chronic HepatitisB infection.
This case also suggests that fibrosis may regress, as
reported by Blumberg et al., despite incomplete removal
of excess iron stores; however, the original amount of
fibrosis in 1977 was minor. The portal tract inflammation in
the first biopsy, in 1977, is unexplained but its resolution by
the following year and absence in the partial hepatectomy
specimen makes it unlikely that it is relevant to the
aetiology oftheHCC.
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